|
1. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Irn Med 2000;3:192-201. 2. WHO. Introduction of hepatits B Vaccine into chidhood immunization services; 2001. 3. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-39. [ DOI:10.1002/hep.21513] [ PMID] 4. Badur S, Akgun A. Diagnosis of hepatitis B infection and monitoring of treatment. J Clin Virol 2001;21:229-37 [ DOI:10.1016/S1386-6532(01)00147-0] 5. Berninger M, Hammer M, Hoyer B, Gerin JL. An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol 1982;9:762-28. [ DOI:10.1002/jmv.1890090109] 6. Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010;51:1933-44. [ DOI:10.1002/hep.23571] [ PMID] 7. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e Antigen-Negative Chronic Hepatitis B. Hepatology 2001;34:617-24. [ DOI:10.1053/jhep.2001.27834] [ PMID] 8. Gowans E. Relationship between HBeAg and HBV DNA in patients with acute and persistent hepatitis B infection. Med J Aust 1986;145:439-41. 9. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 2007;16:403. 10. Lin LY, Wong VW, Zhou HJ, Chan HY, Gui HL, Guo SM, et al. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients. J Med Virol 2010;82:1949-50. [ DOI:10.1002/jmv.21863] [ PMID] 11. Vaez Jalali M, Alavian S. Hepatitis B e antigen-Negative chronic hepatitis B. Hepatitis Monthly 2006;6:5-31. 12. Liaw Y. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B. Hepatol Int 2009;3:425-33. [ DOI:10.1007/s12072-009-9140-3] [ PMID] [ PMCID] 13. Rapicetta M, D Nardo V, Rozera C, Marinucci G, Francisci D, Sarrecchia B, et al. HBV-DNA, HBeAg/anti-HBe serological status in hepatitis B chronic individuals from central Italy. Epidemiol Infect 1990;104:511-7. [ DOI:10.1017/S0950268800047518] [ PMID] [ PMCID] 14. Chen P, Xie Q, Lu X, Yu C, Xu K, Ruan B, et all. Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: a community-based study. Medicine (Baltimore) 2017;96:e7766. [ DOI:10.1097/MD.0000000000007766] [ PMID] [ PMCID] |
